Trv045 placebo

DRUG2 trials

Sponsors

Trevena Inc.

Conditions

Acute and chronic neuropathic pain secondary to diabetic peripheral neuropathyEpilepsy

Phase 1

A phase I, randomized, double-blind, placebo-controlled, four-way cross-over study to evaluate the analgesic effects of TRV045 in healthy adults

CompletedCTIS2022-501804-80-00

Trevena Inc.Acute and chronic neuropathic pain secondary to diabetic peripheral neuropathy

Start: 2022-11-17End: 2023-06-21Target: 24Updated: 2023-03-14

A phase I, randomized, double-blind, placebo-controlled, two-way cross-over, multiple dose study to evaluate the pharmacodynamic effects of TRV045 on the cortical excitability in healthy male adults

CompletedCTIS2022-502638-17-00

Trevena Inc.Epilepsy

Start: 2023-02-03End: 2023-06-09Target: 24Updated: 2023-04-17